Literature DB >> 15196204

Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.

Volker Kunzmann1, Eva Kretzschmar, Thomas Herrmann, Martin Wilhelm.   

Abstract

The recognition of pathogen-associated molecular patterns (PAMPs) by the innate immune system is a crucial step in inducing effective immune responses. Double-stranded RNA [mimicked by polyinosinic-polycytidylic acid (poly(I:C)], synthesized by various types of viruses, represents one important member of these immunostimulatory microbial components. Here we report that poly(I:C) has potent gammadelta T-cell costimulatory capacity. Within peripheral blood mononuclear cells, poly(I:C)-stimulated gammadelta T cells expressed increased levels of CD69 and exhibited significantly enhanced antigen-mediated proliferation in response to isopentenylpyrophosphate (IPP). Among several recombinant cytokines tested, type I interferons (IFN-alpha, IFN-beta) and interleukin-15 (IL-15) showed a similar activation pattern of gammadelta T cells. gammadelta T-cell clones and purified gammadelta T cells did not respond to poly(I:C), indicating indirect effects of this compound. Depletion of CD11c(+) dendritic cells (DC), which express Toll-like receptor 3 (TLR3), known to recognize poly(I:C), abrogated poly(I:C)-mediated stimulation of gammadelta T cells. In addition, the supernatant of poly(I:C)-treated CD11c(+) DC was able to mimic the stimulatory effects of poly(I:C) on gammadelta T cells. Experiments with neutralizing antibodies indicated that type I IFNs, but not IL-15, contributed to the poly(I:C)-mediated activation of gammadelta T cells. In conclusion, gammadelta T-cell activation by immunostimulatory double-stranded RNA, such as poly(I:C), is indirectly mediated via type I IFNs derived from TLR3-expressing CD11c(+) DCs. These results suggest that upon confrontation with certain viruses, gammadelta T cells can be rapidly activated by type I interferons and may contribute to effective antiviral responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196204      PMCID: PMC1782511          DOI: 10.1111/j.1365-2567.2004.01908.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

3.  Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.

Authors:  Misako Matsumoto; Satomi Kikkawa; Masayoshi Kohase; Kensuke Miyake; Tsukasa Seya
Journal:  Biochem Biophys Res Commun       Date:  2002-05-24       Impact factor: 3.575

4.  Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli.

Authors:  M Hintz; A Reichenberg; B Altincicek; U Bahr; R M Gschwind; A K Kollas; E Beck; J Wiesner; M Eberl; H Jomaa
Journal:  FEBS Lett       Date:  2001-12-07       Impact factor: 4.124

5.  Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta.

Authors:  S Rothenfusser; V Hornung; A Krug; A Towarowski; A M Krieg; S Endres; G Hartmann
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

6.  Escherichia coli produces phosphoantigens activating human gamma delta T cells.

Authors:  Juliane Feurle; Eric Espinosa; Susanne Eckstein; Frédéric Pont; Volker Kunzmann; Jean-Jacques Fournié; Markus Herderich; Martin Wilhelm
Journal:  J Biol Chem       Date:  2001-10-23       Impact factor: 5.157

7.  Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease.

Authors:  E Cario; D K Podolsky
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

9.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Authors:  Hiroyuki Oshiumi; Misako Matsumoto; Kenji Funami; Takashi Akazawa; Tsukasa Seya
Journal:  Nat Immunol       Date:  2003-01-21       Impact factor: 25.606

View more
  27 in total

Review 1.  Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Authors:  Tian Wang
Journal:  J Neuroimmunol       Date:  2011-11-10       Impact factor: 3.478

2.  Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.

Authors:  Matthias Eberl; Hassan Jomaa; Adrian C Hayday
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

3.  gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection.

Authors:  Hao Fang; Thomas Welte; Xin Zheng; Gwong-Jen J Chang; Michael R Holbrook; Lynn Soong; Tian Wang
Journal:  FEMS Immunol Med Microbiol       Date:  2010-02-17

Review 4.  gammadelta T lymphocytes-selectable cells within the innate system?

Authors:  Willi K Born; Niyun Jin; M Kemal Aydintug; J M Wands; Jena D French; Christina L Roark; Rebecca L O'Brien
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.317

Review 5.  Modulation of γδ T cell responses by TLR ligands.

Authors:  Daniela Wesch; Christian Peters; Hans-Heinrich Oberg; Kathrin Pietschmann; Dieter Kabelitz
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 6.  The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

Authors:  Domenico Galati; Serena Zanotta; Marialuisa Bocchino; Rosaria De Filippi; Antonio Pinto
Journal:  Cancer Immunol Immunother       Date:  2021-01-01       Impact factor: 6.968

7.  Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.

Authors:  Hannah L Miller; Pali D Shah; Jonathan B Orens; John F McDyer
Journal:  J Heart Lung Transplant       Date:  2013-09       Impact factor: 10.247

8.  Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness.

Authors:  Laura Cook; Nobuaki Miyahara; Niyun Jin; J M Wands; Christian Taube; Christina L Roark; Terry A Potter; Erwin W Gelfand; Rebecca L O'Brien; Willi K Born
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.

Authors:  Carol Inatsuka; Yi Yang; Ekram Gad; Lauren Rastetter; Mary L Disis; Hailing Lu
Journal:  Cancer Immunol Immunother       Date:  2013-05-18       Impact factor: 6.968

10.  Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice.

Authors:  Hussein Sultan; Juan Wu; Takumi Kumai; Andres M Salazar; Esteban Celis
Journal:  Cancer Immunol Immunother       Date:  2018-04-25       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.